Harris Taylor C.
Harris Taylor C.'s purchase track record
Harris Taylor C. has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 9/17/2021 | PRCT | $250K | -36.4% | -17.5% | +0.7% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
THINK Surgical Names Rick McDowell VP of Sales. THINK Surgical, a subsidiary of PROCEPT BioRobotics, has appointed Rick McDowell as Vice President of Sales. This leadership addition is intended to support the company's commercial operations. The stock is currently trading near its 52-week low, with an average analyst target of $21.64.
Transaction History
| ESTA | ▲ Buy | Grant | 1,949 | $0 | 6/24/2026 | View on chart |
| ESTA | ▲ Buy | Grant | 1,281 | $0 | 6/24/2026 | View on chart |
| PRCT | ▲ Buy | Grant | 3,315 | $0 | 6/9/2026 | View on chart |
| PRCT | ▲ Buy | Grant | 1,538 | $0 | 6/10/2025 | View on chart |
| PRCT | ▲ Buy | Option Exercise | 81,550 | $422K | 6/4/2024 | View on chart |
| PRCT | ▲ Buy | Grant | 1,376 | $0 | 6/4/2024 | View on chart |
| PRCT | ▲ Buy | Grant | 2,711 | $0 | 6/15/2023 | View on chart |
| PRCT | ▲ Buy | Grant | 2,001 | $75K | 6/7/2022 | View on chart |
| PRCT | ▲ Buy | Open Market | 10,000 | $250K | 9/17/2021 | View on chart |
| PRCT | ▼ Sell | Other | 35,074 | — | 9/17/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
ESTA Receives FDA Approval for New Motiva Implant Sizes
Establishment Labs Holdings received FDA clearance for additional sizes of its Motiva implants, expanding its product lineup. The company also reported its Q2 2026 financial results. This regulatory approval is a key development for the medical device maker, potentially broadening its market reach.
ESTA Receives FDA Approval for New Motiva Implant Sizes. Establishment Labs Holdings received FDA clearance for additional sizes of its Motiva implants, expanding its product lineup. The company also reported its Q2 2026 financial results. This regulatory approval is a key development for the medical device maker, potentially broadening its market reach.